Clinical Trial Update: A Study to Test if Fremanezumab Reduces Headache in Participants With Posttraumatic Headache (PTH) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating fremanezumab for reducing headaches in post-traumatic headache; trial completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Headache

Drugs mentioned

• Fremanezumab (fremanezumab)

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D, Inc. | Conditions: Post-Traumatic Headache | Phase 2 | Status: COMPLETED | Results posted: 2021-03-26